Jeng-shin Lee

Deputy Director, Harvard Gene Therapy Initiative, Harvard Medical School

Jeng-shin Lee
4 Blackfan Circle
Boston, MA, 02115
Mailstop: HIM, Room 407
Phone: 617-432-6465
Fax: 617-432-6146
jlee@hihg.med.harvard.edu

Not Available.

Assistant Director, Vector

Not Available.

Butler MO, Lee JS, Ansén S, Neuberg D, Hodi FS, Murray AP, Drury L, Berezovskaya A, Mulligan RC, Nadler LM, Hirano N.Long-Lived Antitumor CD8+ Lymphocytes for Adoptive Therapy Generated Using an Artificial Antigen-Presenting Cell.Clin Cancer Res 2007 Mar
17363542
Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC, Hinds PW.The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation.Mol Cell 2001 Aug;8(2):303-16.
11545733

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Jeng-shin Lee Deputy Director, Harvard Gene Therapy Initiative, Harvard Medical School Contact Info Jeng-shin Lee 4 Blackfan Circle Boston, MA, 02115 Mailstop: HIM, Room 407 Phone: 617-432-6465 Fax: 617-432-6146 jlee@hihg.med.harvard.edu Assistant Not Available. DF/HCC Associations Assistant Director, Vector Research Abstract Not Available. Publications Butler MO, Lee JS, Ansén S, Neuberg D, Hodi FS, Murray AP, Drury L, Berezovskaya A, Mulligan RC, Nadler LM, Hirano N.Long-Lived Antitumor CD8+ Lymphocytes for Adoptive Therapy Generated Using an Artificial Antigen-Presenting Cell.Clin Cancer Res 2007 Mar 17363542 Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC, Hinds PW.The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation.Mol Cell 2001 Aug;8(2):303-16. 11545733
Site Map Site Feedback Web Privacy Policy